USP39 and neuroblastoma: Additionally, in the study of tumor prognosis, it was found that USP39 was closely related to the prognosis of patients with hepatocellular carcinoma, pancreatic ductal adenocarcinoma, glioma, neuroblastoma and other malignant tumors.